Atrás
Biocure Technology Inc (BICTF) Dividendos
Gráfico del Precio de Acciones BICTF
BICTF Dividendos
Biocure Technology Inc
$0.01
0%
$0
Al cierre: Mar 24, 16:00:00 GMT-4
$0.01
0%
$0
Mercado Posterior: Mar 24, 20:00:00 GMT-4
Estadísticas clave
Cierre Anterior
$0.01
Precio de apertura
$0.01
Rango del día
$0.01 - $0.07
Rango de 52 semanas
$0.0012 - $0.63
Volumen
1.0K
Volumen promedio
0
Rendimiento de dividendos
--
EPS (TTM)
-0.02
Cap. de mercado
$154.4K
¿Qué es BIOCURE TECHNOLOGY INC?
Biocure Technology, Inc. engages in the development and commercialization of biosimilar products. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2008-03-27. The firm specializes in the development and commercialization of its own CAR T-cell therapy, targeting Chronic lymphocytic leukemia and solid tumor cancers. Additionally, the Company is developing biosimilar technologies for cancer treatment. The Company’s products include Interferon Beta, Ranibizumab and PEG-Filgrastim.
Características
© 2026 Finture Development Limited. Todos los derechos reservados.
